[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.130.145. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Invited Critique
February 2011February 21, 2011

Injection Site Mass Following Sentinel Node Biopsy for Breast CancerComment on “Occurrence of Prolonged Injection Site Mass With Methylene Blue but Not Isosulfan Blue After Sentinel Node Procedure”

Author Affiliations

Author Affiliation: Department of Surgery, University of Alabama at Birmingham.

Arch Surg. 2011;146(2):142. doi:10.1001/archsurg.2010.322

Shirah, Bouton, and Komenaka, of the Maricopa Medical Center in Phoenix, Arizona, distinguish the advantages of isosulfan blue and methylene blue in the use of sentinel lymph node procedures for breast cancer. The authors have identified significant advantages relative to methylene blue injection over that of the commonly used isosulfan blue dye. Advantages of using methylene blue include lack of the anaphylactoid reaction and its interference with pulse oximetry. In addition, a significant advantage to the use of methylene blue is the product cost; the authors estimated that isosulfan blue was 80 times more expensive than methylene blue.

First Page Preview View Large
First page PDF preview
First page PDF preview
×